• Bloomberg

  • SHARE

Japan’s anticipated approval of medical abortion pills may come with a hurdle, requiring women to get approval from their partners before doctors will give them the drugs that have been available for decades in many parts of the world.

The country is considering an application from pharmaceutical company Linepharma International for the tandem medications to terminate pregnancies — mifepristone and misoprostol, currently in use in more than 70 countries.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)